A postdoctoral position is immediately available in the Laboratory of Cancer Epigenetics (ULB – Université Libre de Bruxelles) headed by Prof. François Fuks.
You will be expected to conduct cancer research in epigenetics and epigenomics. Specifically, you will investigate the mechanisms and functions of a novel epigenetic modification. Genetic, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq, ChIP-Seq, Infinium Methylation) will be applied. The lab is running a Next Gen Sequencing Illumina platform and is part of the ULB-Cancer Research Center (U-CRC).
Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related subjects (or have recently submitted their thesis with their defence scheduled). Candidates are required to have a broad experience in molecular and cellular biology techniques. Previous experience in epigenetics is an asset.
The position is funded for 3 years by F.R.S.-FNRS (Fund for Scientific Research). Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date.
Informal enquiries, CV and names of two referees should be send to: Mrs Valentina Albarani, PhD (valentina.albarani.@ulb.ac.be). Phone: +32-2-555 6245. Fax: +32-2-555 6257.
Selected publications:
- Brenner et al. EMBO J. 2005
- Viré et al. Nature 2006
- Brenner & Fuks Dev. Cell 2007
- Villa et al. Cancer Cell 2007
- Epsztejn-Litman et al. Nature SMB. 2008
- Fuks F. Nature. 2010
- Dedeurwaerder et al. EMBO Mol Med 2011
- Volkmar et al. EMBO J. 2012
- Deplus et al. EMBO J. 2013
- Delatte et al. EMBO J. 2014
- Deplus et al. Cell Reports 2014
- Boumahdi et al. Nature 2014
- Delatte et al. Science Rep 2015…
You will be expected to conduct cancer research in epigenetics and epigenomics. Specifically, you will investigate the mechanisms and functions of a novel epigenetic modification. Genetic, biochemical and cell biological as well as genome-wide approaches (e.g. RNA-Seq, ChIP-Seq, Infinium Methylation) will be applied. The lab is running a Next Gen Sequencing Illumina platform and is part of the ULB-Cancer Research Center (U-CRC).
Applicants should hold a PhD degree in Biochemistry/Molecular Biology or related subjects (or have recently submitted their thesis with their defence scheduled). Candidates are required to have a broad experience in molecular and cellular biology techniques. Previous experience in epigenetics is an asset.
The position is funded for 3 years by F.R.S.-FNRS (Fund for Scientific Research). Screening of applications begins immediately and continues until an outstanding candidate is selected. Flexible starting date.
Informal enquiries, CV and names of two referees should be send to: Mrs Valentina Albarani, PhD (valentina.albarani.@ulb.ac.be). Phone: +32-2-555 6245. Fax: +32-2-555 6257.
Selected publications:
- Brenner et al. EMBO J. 2005
- Viré et al. Nature 2006
- Brenner & Fuks Dev. Cell 2007
- Villa et al. Cancer Cell 2007
- Epsztejn-Litman et al. Nature SMB. 2008
- Fuks F. Nature. 2010
- Dedeurwaerder et al. EMBO Mol Med 2011
- Volkmar et al. EMBO J. 2012
- Deplus et al. EMBO J. 2013
- Delatte et al. EMBO J. 2014
- Deplus et al. Cell Reports 2014
- Boumahdi et al. Nature 2014
- Delatte et al. Science Rep 2015…
為防止簡(jiǎn)歷投遞丟失請(qǐng)抄送一份至：boshijob@126.com（郵件標(biāo)題格式：應(yīng)聘職位名稱(chēng)+姓名+學(xué)歷+專(zhuān)業(yè)+中國(guó)博士人才網(wǎng)）
中國(guó)-博士人才網(wǎng)發(fā)布
聲明提示：凡本網(wǎng)注明“來(lái)源：XXX”的文/圖等稿件，本網(wǎng)轉(zhuǎn)載出于傳遞更多信息及方便產(chǎn)業(yè)探討之目的，并不意味著本站贊同其觀點(diǎn)或證實(shí)其內(nèi)容的真實(shí)性，文章內(nèi)容僅供參考。
